Literature DB >> 33454017

Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Julie Pilliod1, Alexandre Desjardins1, Camille Pernègre2, Hélène Jamann2, Catherine Larochelle2, Edward A Fon3, Nicole Leclerc4.   

Abstract

In Alzheimer's disease (AD), tau, a microtubule-associated protein (MAP), becomes hyperphosphorylated, aggregates, and accumulates in the somato-dendritic compartment of neurons. In parallel to its intracellular accumulation in AD, tau is also released in the extracellular space, as revealed by its increased presence in cerebrospinal fluid (CSF). Consistent with this, recent studies, including ours, have reported that neurons secrete tau, and several therapeutic strategies aim to prevent the intracellular tau accumulation. Previously, we reported that late endosomes were implicated in tau secretion. Here, we explore the possibility of preventing intracellular tau accumulation by increasing tau secretion. Using neuronal models, we investigated whether overexpression of the vesicle-associated membrane protein 8 (VAMP8), an R-SNARE found on late endosomes, could increase tau secretion. The overexpression of VAMP8 significantly increased tau secretion, decreasing its intracellular levels in the neuroblastoma (N2a) cell line. Increased tau secretion by VAMP8 was also observed in murine hippocampal slices. The intracellular reduction of tau by VAMP8 overexpression correlated to a decrease of acetylated tubulin induced by tau overexpression in N2a cells. VAMP8 staining was preferentially found on late endosomes in N2a cells. Using total internal reflection fluorescence (TIRF) microscopy, the fusion of VAMP8-positive vesicles with the plasma membrane was correlated to the depletion of tau in the cytoplasm. Finally, overexpression of VAMP8 reduced the intracellular accumulation of tau mutants linked to frontotemporal dementia with parkinsonism and α-synuclein by increasing their secretion. Collectively, the present data indicate that VAMP8 could be used to increase tau and α-synuclein clearance to prevent their intracellular accumulation.
Copyright © 2020 © 2020 Pilliod et al. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; SNARE proteins; TIRF microscopy; Tau protein (Tau); VAMP8; endosome; late endosomes; secretion; tau mutants

Mesh:

Substances:

Year:  2020        PMID: 33454017      PMCID: PMC7762943          DOI: 10.1074/jbc.RA120.013553

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Characteristics and consequences of muscarinic receptor activation by tau protein.

Authors:  Alberto Gómez-Ramos; Miguel Díaz-Hernández; Alicia Rubio; Juan Ignacio Díaz-Hernández; Maria Teresa Miras-Portugal; Jesus Avila
Journal:  Eur Neuropsychopharmacol       Date:  2009-05-07       Impact factor: 4.600

Review 2.  Rab proteins and the compartmentalization of the endosomal system.

Authors:  Angela Wandinger-Ness; Marino Zerial
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

3.  VAMP8/endobrevin as a general vesicular SNARE for regulated exocytosis of the exocrine system.

Authors:  Cheng-Chun Wang; Hong Shi; Ke Guo; Chee Peng Ng; Jie Li; Bin Qi Gan; Hwee Chien Liew; Jukka Leinonen; Hannu Rajaniemi; Zhi Hong Zhou; Qi Zeng; Wanjin Hong
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

4.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

5.  A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal.

Authors:  Tuanlao Wang; Ming Zhang; Zexu Ma; Ke Guo; Vinay Tergaonkar; Qi Zeng; Wanjin Hong
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 6.  Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases.

Authors:  Ralph A Nixon
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

7.  Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis.

Authors:  I Alafuzoff; K Iqbal; H Friden; R Adolfsson; B Winblad
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 8.  Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Authors:  Harald Hampel; Kaj Blennow; Leslie M Shaw; Yvonne C Hoessler; Henrik Zetterberg; John Q Trojanowski
Journal:  Exp Gerontol       Date:  2009-10-22       Impact factor: 4.032

9.  Physiological release of endogenous tau is stimulated by neuronal activity.

Authors:  Amy M Pooler; Emma C Phillips; Dawn H W Lau; Wendy Noble; Diane P Hanger
Journal:  EMBO Rep       Date:  2013-02-15       Impact factor: 8.807

10.  Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons.

Authors:  Nguyen-Vi Mohamed; Vanessa Plouffe; Gaudeline Rémillard-Labrosse; Emmanuel Planel; Nicole Leclerc
Journal:  Sci Rep       Date:  2014-07-17       Impact factor: 4.379

View more
  5 in total

Review 1.  Role of SNAREs in Unconventional Secretion-Focus on the VAMP7-Dependent Secretion.

Authors:  Somya Vats; Thierry Galli
Journal:  Front Cell Dev Biol       Date:  2022-06-16

Review 2.  Role of SNAREs in Neurodegenerative Diseases.

Authors:  Azzurra Margiotta
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

3.  Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer's disease.

Authors:  Xiaonan Wang; Di Wang; Fei Su; Chunmei Li; Min Chen
Journal:  Ann Transl Med       Date:  2022-01

4.  Concurrent suppression of Aβ aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease.

Authors:  Tao Yang; Lei Zhang; Yicun Shang; Zhenzhu Zhu; Suxing Jin; Zijian Guo; Xiaoyong Wang
Journal:  Chem Sci       Date:  2022-02-21       Impact factor: 9.825

5.  Smuggle tau through a secret(ory) pathway.

Authors:  Hao Xu 徐昊
Journal:  Biochem J       Date:  2021-07-30       Impact factor: 3.766

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.